| Sandoz Pharmaceuticals AG - Lisitril 30, Tabletten |
| 56061 | | 04 | | Lisitril 30 | | Tabletten | | C09AA03 | | Lisinopril | | 22.11.2004 | | |
|
| Composition |
| lisinoprilum 30 mg ut lisinoprilum dihydricum, calcii hydrogenophosphas dihydricus, mannitolum, maydis amylum, carmellosum natricum conexum corresp. natrium 1.08 mg, magnesii stearas, E 172 (rubrum), pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Lisinopril | 30 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lisinopril | 30 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Rubrum) | | | | Calcium Hydrogenophosphate Dihydrate | | | | Carmellosum Natricum Conexum | | | | E 172 | | color. | | Magnesii Stearas | | | | Mannitol | | | | Maydis Amylum | | | | Pro Compresso | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 014 | 30 Comprimé(s) | 7.84 | 17.75 | B | LS | Non | | 016 | 100 Comprimé(s) | 24.35 | 42.90 | B | LS | Non |
|
